The Safety and Efficacy of Zanubrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia
Condition:   Refractory/Relapsed Autoimmune Hemolytic Anemia Intervention:   Drug: Zanubrutinib Sponsor:   Institute of Hematology & Blood Diseases Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials

Autoimmune and Inflammatory Response Biomarkers in Fabry Disease
Condition:   Fabry Disease Intervention:   Sponsors:   Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal;   Fundación Mutua Madrileña Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials